Literature DB >> 16652388

Expression of mTOR signaling pathway markers in prostate cancer progression.

Celeste L Kremer1, Rob R Klein, Jenny Mendelson, Walden Browne, Linda K Samadzedeh, Kristie Vanpatten, Lindsey Highstrom, Gary A Pestano, Raymond B Nagle.   

Abstract

BACKGROUND: The PI3K/AKT/mTOR pathway is central to prostate cancer progression. A preliminary investigation of immuno-histochemical expression of mammalian target of rapamycin (mTOR) pathway markers was undertaken to identify patterns of expression in prostate tissue.
METHODS: Immunohistochemistry was performed on a custom-made prostate tissue array. Mean long scores and variability of long scores for each marker were recorded for normal lumenal cells, prostate intraepithelial neoplasia (PIN), and cancer.
RESULTS: Expression of PTEN decreased and mTOR signaling pathway markers increased in PIN and in cancer as compared to normal cells in the majority of samples. Overexpression of 4E-BP1 and p-4E-BP1 was observed in PIN and cancer. However, in cancer, the overexpression of 4E-BP1 was significantly higher than with any other marker. DISCUSSION: Results suggest that 4E-BP1 overexpression is strongly associated with prostate cancer, especially when combined with PTEN and mTOR expression data. Hierarchical clustering analysis utilizing PTEN, mTOR, and 4E-BP1 separated normal from cancer cell populations in most cases. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652388     DOI: 10.1002/pros.20410

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  73 in total

1.  Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.

Authors:  Nicole D Facompre; Indu Sinha; Karam El-Bayoumy; John T Pinto; Raghu Sinha
Journal:  Int J Cancer       Date:  2012-03-20       Impact factor: 7.396

2.  Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.

Authors:  Achinto Saha; Jorge Blando; Lisa Tremmel; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

3.  ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Jaime M C Gard; Raymond B Nagle; Justin D Dietrich; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-08-02       Impact factor: 4.849

Review 4.  4E-BP1, a multifactor regulated multifunctional protein.

Authors:  Xiaoyu Qin; Bin Jiang; Yanjie Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.

Authors:  Rafik Boudra; Rosyne Lagrafeuille; Corinne Lours-Calet; Cyrille de Joussineau; Gaëlle Loubeau-Legros; Cédric Chaveroux; Jean-Paul Saru; Silvère Baron; Laurent Morel; Claude Beaudoin
Journal:  Cell Cycle       Date:  2016-05-18       Impact factor: 4.534

6.  Expression and clinical significance of mammalian target of rapamycin/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue.

Authors:  Qingjun Lu; Jieshu Wang; Gang Yu; Tianhua Guo; Chun Hu; Peng Ren
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

Review 7.  Common corruption of the mTOR signaling network in human tumors.

Authors:  S Menon; B D Manning
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

Review 8.  Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.

Authors:  Vaqar Mustafa Adhami; Deeba Nadeem Syed; Naghma Khan; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2012-07-25       Impact factor: 5.858

9.  A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.

Authors:  Olga C Rodriguez; Edwin W Lai; Sarada Vissapragada; Caroline Cromelin; Maral Avetian; Patricia Salinas; Hida Ramos; Bhaskar Kallakury; Mathew Casimiro; Michael P Lisanti; Herbert B Tanowitz; Karel Pacak; Robert I Glazer; Maria Avantaggiati; Chris Albanese
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

Review 10.  The Par-4/PTEN connection in tumor suppression.

Authors:  Maria T Diaz-Meco; Shadi Abu-Baker
Journal:  Cell Cycle       Date:  2009-08-29       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.